Kabra Drugs Limited (BOM:524322)
31.00
+0.63 (2.07%)
At close: Mar 5, 2026
193.56% (1Y)
| Market Cap | 724.27M +3,418.9% |
| Revenue (ttm) | 573.34M |
| Net Income | 42.96M |
| EPS | 2.03 |
| Shares Out | 23.71M |
| PE Ratio | 15.02 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 42,438 |
| Average Volume | 134,847 |
| Open | 30.37 |
| Previous Close | 30.37 |
| Day's Range | 30.00 - 31.50 |
| 52-Week Range | 10.56 - 35.52 |
| Beta | -0.35 |
| RSI | 51.05 |
| Earnings Date | Feb 13, 2026 |